PolarityTE Inc

PolarityTE Inc PTE

Dividend Summary


The previous PolarityTE Inc dividend was 33.55c and it went ex almost 7 years ago and it was paid almost 7 years ago.
There have not been any declared dividends recently.

Latest Dividends
Summary Previous dividend Next dividend
Status Paid
Type Special
Per share 33.55c
Declaration date 06 Jan 2016 (Wed)
Ex-div date 19 Jan 2016 (Tue)
Pay date 15 Jan 2016 (Fri)

Enter the number of PolarityTE Inc shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for PolarityTE Inc
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for PolarityTE Inc
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Paid Special 06 Jan 2016 19 Jan 2016 15 Jan 2016 USD 33.55c
Year Amount Change
2006 0.0c
2007 0.0c
0%
2008 0.0c
0%
2009 0.0c
0%
2010 0.0c
0%
2011 0.0c
0%
2012 0.0c
0%
2013 0.0c
0%
2014 0.0c
0%
2015 0.0c
0%
2016 0.0c
0%
2017 0.0c
0%
2018 0.0c
0%
2019 0.0c
0%
2020 0.0c
0%
2021 0.0c
0%
2022 Sign Up Required

PolarityTE Inc Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on 10 January 2022
52 Week Low
0.0% on 10 January 2022
Next Ex-Div-Date Countdown
Sign Up Required

About PolarityTE Inc

PolarityTE, Inc. is a biotechnology company. The Company is focused on developing regenerative tissue products and biomaterials. It also operates a laboratory testing and clinical research business using equipment, personnel, and facilities it acquired to advance its development of regenerative tissue products. Its first regenerative tissue product is SkinTE, which is intended for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The Company's development projects include SkinTE Cryo, SkinTE point-of-care device, PTE 11000, and others.

Sector
Pharmaceuticals & Biotechnology
Country
United States
Share Price
$0.70 (yesterday's closing price)
Shares in Issue
7 million
Market Cap
$5mn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
none
No articles found